Department of Medicine and Service of Cytometry, IBSAL and Centro de Investigación del Cáncer (IBMCC USAL-CSIC), University Hospital of Salamanca and University of Salamanca, Salamanca, Spain.
Haematologica. 2013 Feb;98(2):279-87. doi: 10.3324/haematol.2011.060632. Epub 2012 Aug 28.
Cytogenetic studies in clonal plasma cell disorders have mainly been done in whole bone marrow or CD138(+) microbead-enriched plasma cells and suggest that recurrent immunoglobulin heavy chain translocations - e.g. t(4;14) -are primary oncogenetic events. The aim of this study was to determine cytogenetic patterns of highly purified aberrant plasma cells (median purity ≥ 98%) in different clonal plasma cell disorders. We analyzed aberrant plasma cells from 208 patients with multiple myeloma (n=148) and monoclonal gammopathy of undetermined significance (n=60) for the presence of del(13q14), del(17p13) and t(14q32) using multicolor interphase fluorescence in situ hybridization. Additionally, immunoglobulin heavy chain gene arrangements were analyzed and complementarity determining region 3 was sequenced in a subset of patients and combined multicolor interphase fluorescence in situ hybridization/immunofluorescent protein staining analyses were performed in selected cases to confirm clonality and cytogenetic findings. At diagnosis, 96% of cases with multiple myeloma versus 77% of monoclonal gammopathy of undetermined significance cases showed at least one cytogenetic alteration and/or hyperdiploidy. The cytogenetic heterogeneity of individual cases reflected coexistence of cytogenetically-defined aberrant plasma cell clones, and led to the assumption that karyotypic alterations were acquired stepwise. Cases of multiple myeloma and monoclonal gammopathy of undetermined significance frequently showed different but related cytogenetic profiles when other cytogenetic alterations such as deletions/gains of the immunoglobulin heavy chain or the fibroblast growth factor receptor 3 were additionally considered. Interestingly, in 24% of multiple myeloma versus 62% of monoclonal gammopathy of undetermined significance patients with an immunoglobulin heavy chain translocation, aberrant plasma cells with and without t(14q32) coexisted in the same patient. Our data suggest that recurrent immunoglobulin heavy chain translocations might be absent in the primordial plasma cell clone in a significant proportion of patients with clonal plasma cell disorders carrying these cytogenetic alterations.
克隆性浆细胞疾病的细胞遗传学研究主要在整个骨髓或 CD138(+)微珠富集的浆细胞中进行,并提示反复出现的免疫球蛋白重链易位 - 例如 t(4;14) - 是原发性肿瘤发生事件。本研究的目的是确定不同克隆性浆细胞疾病中高度纯化的异常浆细胞(中位数纯度≥98%)的细胞遗传学模式。我们使用多色间期荧光原位杂交分析了 208 例多发性骨髓瘤(n=148)和单克隆丙种球蛋白病(n=60)患者的异常浆细胞,以检测 del(13q14)、del(17p13)和 t(14q32)的存在。此外,在部分患者中分析免疫球蛋白重链基因重排,并对互补决定区 3 进行测序,并在选定病例中进行组合多色间期荧光原位杂交/免疫荧光蛋白染色分析,以确认克隆性和细胞遗传学发现。在诊断时,96%的多发性骨髓瘤病例与 77%的单克隆丙种球蛋白病病例至少出现一种细胞遗传学改变和/或超二倍体。个别病例的细胞遗传学异质性反映了细胞遗传学定义的异常浆细胞克隆的共存,并假设核型改变是逐步获得的。当考虑到其他细胞遗传学改变,如免疫球蛋白重链缺失/获得或成纤维细胞生长因子受体 3 缺失/获得时,多发性骨髓瘤和单克隆丙种球蛋白病病例通常表现出不同但相关的细胞遗传学特征。有趣的是,在 24%的多发性骨髓瘤病例和 62%的单克隆丙种球蛋白病病例中,携带免疫球蛋白重链易位的异常浆细胞中存在和不存在 t(14q32)的细胞同时存在于同一患者中。我们的数据表明,在携带这些细胞遗传学改变的克隆性浆细胞疾病患者中,相当一部分患者的原始浆细胞克隆中可能不存在反复出现的免疫球蛋白重链易位。